[go: up one dir, main page]

WO2002030951A3 - Haplotypes du gene cyp1b1 - Google Patents

Haplotypes du gene cyp1b1 Download PDF

Info

Publication number
WO2002030951A3
WO2002030951A3 PCT/US2001/042726 US0142726W WO0230951A3 WO 2002030951 A3 WO2002030951 A3 WO 2002030951A3 US 0142726 W US0142726 W US 0142726W WO 0230951 A3 WO0230951 A3 WO 0230951A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
cyp1b1
gene
disclosed
cyp1b1 gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/042726
Other languages
English (en)
Other versions
WO2002030951A2 (fr
Inventor
Jin-Hua Han
Stefanie E Kliem
Angela Sanchis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Priority to AU1192102A priority Critical patent/AU1192102A/xx
Publication of WO2002030951A2 publication Critical patent/WO2002030951A2/fr
Publication of WO2002030951A3 publication Critical patent/WO2002030951A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne de nouveaux variants génétiques du gène (CYP1B1) du Cytochrome P450, sous-famille I (inductible par la dioxine), polypeptide 1 (glaucome 3, primaire infantile). Elle concerne également divers génotypes, haplotypes, et paires d'haplotypes du gène CYP1B1 existants dans la population générale des Etats-Unis. L'invention concerne en outre des compositions et des méthodes d'haplotypage et/ou de génotypage du gène CYP1B1 chez un individu. Elle concerne enfin des polynucléotides définis par les haplotypes de l'invention.
PCT/US2001/042726 2000-10-13 2001-10-15 Haplotypes du gene cyp1b1 Ceased WO2002030951A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU1192102A AU1192102A (en) 2000-10-13 2001-10-15 Haplotypes of the cyp1b1 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24021100P 2000-10-13 2000-10-13
US60/240,211 2000-10-13

Publications (2)

Publication Number Publication Date
WO2002030951A2 WO2002030951A2 (fr) 2002-04-18
WO2002030951A3 true WO2002030951A3 (fr) 2002-07-04

Family

ID=22905591

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/042726 Ceased WO2002030951A2 (fr) 2000-10-13 2001-10-15 Haplotypes du gene cyp1b1

Country Status (2)

Country Link
AU (1) AU1192102A (fr)
WO (1) WO2002030951A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004683A2 (fr) * 2000-07-11 2002-01-17 Vanderbilt University Methode de detection d'une sensibilite accrue au cancer du sein
EP1922417A2 (fr) * 2005-06-23 2008-05-21 Pomeranian Academy of Medicine Procedes, utilisations et compositions destines a la detection d'une predisposition accrue ou reduite a divers cancers par identification de genotypes specifiques du gene cyp1b1
EP1943358B1 (fr) * 2005-09-12 2015-03-04 Government of the USA, as Represented by the Secretary, Department of Health and Human Services Genotype cyp1b1
PL2134876T3 (pl) * 2006-06-22 2014-10-31 Pomorski Univ Medyczny Określanie predyspozycji do raka piersi poprzez identyfikację kombinacji genotypu specyficznych wariantów genów CYP1B1, BRCA2 oraz CHEK2
GB0803071D0 (en) 2008-02-20 2008-03-26 Care Technologies Inc Cancer detection methods and techniques

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SUTTER T.R. ET AL.: "Complete cDNA sequence of a human dioxin-induble mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 269, May 1994 (1994-05-01), pages 13092 - 13099, XP000652286 *
TANG Y.M. ET AL.: "Isolation and characterization of the human cytochrome P450 CYP1B1 gene", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 271, November 1996 (1996-11-01), pages 28324 - 28330, XP002068982 *

Also Published As

Publication number Publication date
AU1192102A (en) 2002-04-22
WO2002030951A2 (fr) 2002-04-18

Similar Documents

Publication Publication Date Title
WO2002026768A3 (fr) Haplotypes du gene por
WO2002038589A3 (fr) Haplotypes du gene cyp2d6
WO2002030951A3 (fr) Haplotypes du gene cyp1b1
WO2002006294A3 (fr) Haplotypes du gene mmp13
WO2002046209A3 (fr) Haplotypes du gene cyp3a5
WO2001079224A3 (fr) Haplotypes du gene cyp8b1
WO2002062820A3 (fr) Haplotypes du gene cyp27b1
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2002036608A3 (fr) Haplotypes du gene cyp1a2
WO2002018414A3 (fr) Haplotypes du gène bf
WO2002010454A3 (fr) Haplotypes du gene alas2? ¿
WO2002090512A3 (fr) Haplotypes du gene nnmt
WO2002040503A3 (fr) Haplotypes du gène plau
WO2002030952A3 (fr) Haplotypes du gene cyp27a1
WO2002063044A3 (fr) Haplotypes du gene il15
WO2002032930A3 (fr) Haplotypes du gene scya21
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2001079223A3 (fr) Haplotypes du gene akr1b1
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002042320A3 (fr) Haplotypes du gene de glutathione reductase
WO2002053579A3 (fr) Haplotypes du gene fmo2
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2002012499A3 (fr) Haplotypes du gene ntf3

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP